Filing Details

Accession Number:
0001209191-23-039059
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-22 16:25:16
Reporting Period:
2023-06-20
Accepted Time:
2023-06-22 16:25:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1787400 Nkarta Inc. NKTX Pharmaceutical Preparations (2834) 474515206
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1853197 Ralph Brandenberger C/O Nkarta, Inc.
6000 Shoreline Court, Suite 102
South San Francisco CA 94080
Chief Technical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-20 221 $4.85 28,088 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person.